Risk factors for invasive fungal infections in adult patients with hematological malignancies and/or stem cell transplant: a systematic review and meta-analysis

Abstract Improving prevention and treatment strategies for invasive fungal infections (IFI) is essential to reduce associated morbidity and mortality. We performed a systematic review and meta-analyses to assess factors associated with IFI in adult patients with hematological malignancies and/or hem...

Full description

Saved in:
Bibliographic Details
Main Authors: Emmanuelle Gras, Patricia Monzo-Gallo, Loris Azoyan, Carolina Garcia-Vidal, Fanny Lanternier, Eolia Brissot, Juliette Guitard, Karine Lacombe, Agnès Dechartres, Laure Surgers
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-16066-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849226341637947392
author Emmanuelle Gras
Patricia Monzo-Gallo
Loris Azoyan
Carolina Garcia-Vidal
Fanny Lanternier
Eolia Brissot
Juliette Guitard
Karine Lacombe
Agnès Dechartres
Laure Surgers
author_facet Emmanuelle Gras
Patricia Monzo-Gallo
Loris Azoyan
Carolina Garcia-Vidal
Fanny Lanternier
Eolia Brissot
Juliette Guitard
Karine Lacombe
Agnès Dechartres
Laure Surgers
author_sort Emmanuelle Gras
collection DOAJ
description Abstract Improving prevention and treatment strategies for invasive fungal infections (IFI) is essential to reduce associated morbidity and mortality. We performed a systematic review and meta-analyses to assess factors associated with IFI in adult patients with hematological malignancies and/or hematopoietic stem cell transplantation (HSCT). Data sources. We searched PubMed, Embase, CENTRAL and the grey literature from 01/01/2002 to 08/02/2024. Study eligibility criteria. Eligible studies were case-control or cohort studies including adult patients with hematological malignancies and/or HSCT and reporting risk factors for IFI. Participants. Adult patients with hematological malignancies and/or HSCT. Assessment of risk of bias. Risk of bias assessment was assessed independently using the Critical Appraisal Skills Programme checklists for cohort studies and case-control studies. Methods of data synthesis. Study selection and data extraction were done independently. Adjusted estimates were pooled using random effects models. Among 12 624 references identified, 69 studies (reporting 2917 IFI) were included in the systematic review, 20 of which were included in meta-analyses. Factors independently associated with IFI included previous allo-HSCT (pooled aHR 3.21 [95%CI 1.54–6.71]), especially with a haploidentical donor (pooled aHR 2.41 [95%CI 1.27–4.57]), acute graft vs. host disease (aGvHD) ≥ 2 (pooled aHR 2.59 [95%CI 1.36–4.90]), corticosteroids (pooled aOR 2.84 [95%CI 1.42–5.70]) or T-cell depleting agents (pooled aOR 2.73 [95%CI 1.61–4.64]). Antifungal prophylaxis was a protective factor for IFI (pooled aOR 0.20 [95%CI 0.13–0.28]). The identification of factors independently associated with IFI may help to stratify IFI risk among hematological patients. Registration: PROSPERO, CRD42023429103.
format Article
id doaj-art-389acc313c72426cbb44fbcec8ab5117
institution Kabale University
issn 2045-2322
language English
publishDate 2025-08-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-389acc313c72426cbb44fbcec8ab51172025-08-24T11:25:08ZengNature PortfolioScientific Reports2045-23222025-08-0115111110.1038/s41598-025-16066-6Risk factors for invasive fungal infections in adult patients with hematological malignancies and/or stem cell transplant: a systematic review and meta-analysisEmmanuelle Gras0Patricia Monzo-Gallo1Loris Azoyan2Carolina Garcia-Vidal3Fanny Lanternier4Eolia Brissot5Juliette Guitard6Karine Lacombe7Agnès Dechartres8Laure Surgers9Sorbonne Université, INSERM, Institut Pierre Louis d’Épidémiologie et de Santé PubliqueDepartment of Infectious Diseases, Hospital Clinic of Barcelona, IDIBAPSSorbonne Université, INSERM, Institut Pierre Louis d’Épidémiologie et de Santé PubliqueDepartment of Infectious Diseases, Hospital Clinic of Barcelona, IDIBAPSNational Reference Center for Invasives Mycoses and Antifungals, Mycology Department, Institut Pasteur, Paris Cité UniversityService d’ Hématologie Clinique et Thérapie Cellulaire, GHU AP-HP. Sorbonne Université, Hôpital Saint-AntoineLaboratoire de parasitologie-Mycologie, Iserm, Sorbonne University, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Hôpital Saint-AntoineSorbonne Université, INSERM, Institut Pierre Louis d’Épidémiologie et de Santé PubliqueDépartement de Santé Publique, Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié-Salpêtrière, Centre de Pharmacoépidémiologie de l’AP-HP (Cephepi)Sorbonne Université, INSERM, Institut Pierre Louis d’Épidémiologie et de Santé PubliqueAbstract Improving prevention and treatment strategies for invasive fungal infections (IFI) is essential to reduce associated morbidity and mortality. We performed a systematic review and meta-analyses to assess factors associated with IFI in adult patients with hematological malignancies and/or hematopoietic stem cell transplantation (HSCT). Data sources. We searched PubMed, Embase, CENTRAL and the grey literature from 01/01/2002 to 08/02/2024. Study eligibility criteria. Eligible studies were case-control or cohort studies including adult patients with hematological malignancies and/or HSCT and reporting risk factors for IFI. Participants. Adult patients with hematological malignancies and/or HSCT. Assessment of risk of bias. Risk of bias assessment was assessed independently using the Critical Appraisal Skills Programme checklists for cohort studies and case-control studies. Methods of data synthesis. Study selection and data extraction were done independently. Adjusted estimates were pooled using random effects models. Among 12 624 references identified, 69 studies (reporting 2917 IFI) were included in the systematic review, 20 of which were included in meta-analyses. Factors independently associated with IFI included previous allo-HSCT (pooled aHR 3.21 [95%CI 1.54–6.71]), especially with a haploidentical donor (pooled aHR 2.41 [95%CI 1.27–4.57]), acute graft vs. host disease (aGvHD) ≥ 2 (pooled aHR 2.59 [95%CI 1.36–4.90]), corticosteroids (pooled aOR 2.84 [95%CI 1.42–5.70]) or T-cell depleting agents (pooled aOR 2.73 [95%CI 1.61–4.64]). Antifungal prophylaxis was a protective factor for IFI (pooled aOR 0.20 [95%CI 0.13–0.28]). The identification of factors independently associated with IFI may help to stratify IFI risk among hematological patients. Registration: PROSPERO, CRD42023429103.https://doi.org/10.1038/s41598-025-16066-6Invasive fungal infectionHematological malignancyHematogenous stem cell transplantationSystematic reviewRisk factors
spellingShingle Emmanuelle Gras
Patricia Monzo-Gallo
Loris Azoyan
Carolina Garcia-Vidal
Fanny Lanternier
Eolia Brissot
Juliette Guitard
Karine Lacombe
Agnès Dechartres
Laure Surgers
Risk factors for invasive fungal infections in adult patients with hematological malignancies and/or stem cell transplant: a systematic review and meta-analysis
Scientific Reports
Invasive fungal infection
Hematological malignancy
Hematogenous stem cell transplantation
Systematic review
Risk factors
title Risk factors for invasive fungal infections in adult patients with hematological malignancies and/or stem cell transplant: a systematic review and meta-analysis
title_full Risk factors for invasive fungal infections in adult patients with hematological malignancies and/or stem cell transplant: a systematic review and meta-analysis
title_fullStr Risk factors for invasive fungal infections in adult patients with hematological malignancies and/or stem cell transplant: a systematic review and meta-analysis
title_full_unstemmed Risk factors for invasive fungal infections in adult patients with hematological malignancies and/or stem cell transplant: a systematic review and meta-analysis
title_short Risk factors for invasive fungal infections in adult patients with hematological malignancies and/or stem cell transplant: a systematic review and meta-analysis
title_sort risk factors for invasive fungal infections in adult patients with hematological malignancies and or stem cell transplant a systematic review and meta analysis
topic Invasive fungal infection
Hematological malignancy
Hematogenous stem cell transplantation
Systematic review
Risk factors
url https://doi.org/10.1038/s41598-025-16066-6
work_keys_str_mv AT emmanuellegras riskfactorsforinvasivefungalinfectionsinadultpatientswithhematologicalmalignanciesandorstemcelltransplantasystematicreviewandmetaanalysis
AT patriciamonzogallo riskfactorsforinvasivefungalinfectionsinadultpatientswithhematologicalmalignanciesandorstemcelltransplantasystematicreviewandmetaanalysis
AT lorisazoyan riskfactorsforinvasivefungalinfectionsinadultpatientswithhematologicalmalignanciesandorstemcelltransplantasystematicreviewandmetaanalysis
AT carolinagarciavidal riskfactorsforinvasivefungalinfectionsinadultpatientswithhematologicalmalignanciesandorstemcelltransplantasystematicreviewandmetaanalysis
AT fannylanternier riskfactorsforinvasivefungalinfectionsinadultpatientswithhematologicalmalignanciesandorstemcelltransplantasystematicreviewandmetaanalysis
AT eoliabrissot riskfactorsforinvasivefungalinfectionsinadultpatientswithhematologicalmalignanciesandorstemcelltransplantasystematicreviewandmetaanalysis
AT julietteguitard riskfactorsforinvasivefungalinfectionsinadultpatientswithhematologicalmalignanciesandorstemcelltransplantasystematicreviewandmetaanalysis
AT karinelacombe riskfactorsforinvasivefungalinfectionsinadultpatientswithhematologicalmalignanciesandorstemcelltransplantasystematicreviewandmetaanalysis
AT agnesdechartres riskfactorsforinvasivefungalinfectionsinadultpatientswithhematologicalmalignanciesandorstemcelltransplantasystematicreviewandmetaanalysis
AT lauresurgers riskfactorsforinvasivefungalinfectionsinadultpatientswithhematologicalmalignanciesandorstemcelltransplantasystematicreviewandmetaanalysis